NDC11 66993045730
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 66993-0457-30 | 66993-0457 |
| 66993-457-30 | 66993-457 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | Prasco Laboratories | 3aba33aa-f8c6-4b10-85c8-dfa14578d07c | 2026-06-03 | Warnings, Adverse reactions | 66993-457-30 66993-457 66993045730 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.